Your session is about to expire
← Back to Search
Cannabinoids for Postoperative Pain and Osteoarthritis Following TKA
This trial will assess whether adding CBD to usual care before and after surgery can reduce the rate of persistent post-surgical pain after total knee replacement.
- Osteoarthritis of the Knee
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a Location
Who is running the clinical trial?
- You have a problem with drugs or alcohol, as defined by doctors using specific criteria.You are allergic or intolerant to cannabis or any ingredients in the study drug.You have previously undergone revision total knee replacement surgery.You have had knee replacement surgery on both knees.You have chronic knee pain that is not caused by osteoarthritis. If your knee pain is due to fibromyalgia or chronic pain syndrome, you will not be eligible for the study.You have a serious heart or lung condition that affects your daily activities and requires constant medical attention.
- Group 1: MPL-001 (CBD: THC 25:1)
- Group 2: Placebo
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the FDA released any guidance on CBD usage?
"There is some evidence that CBD is effective, and it has been studied multiple times, so it received a score of 3."
Is there precedent for CBD as a medication?
"As of now, 83 clinical trials for Cannabidiol (CBD) are ongoing. Of these, 18 are in Phase 3. The numerous studies for Cannabidiol (CBD) have their origins in Ribeirao Preto, Sao Paulo, but expanded to 311 locations."
Share this study with friends